Vectorite Biomedical Stock

Vectorite Biomedical Net Margin

The Net Profit Margin of Vectorite Biomedical (4170.TWO) as of Jul 24, 2026 is -69.33 %. In the previous year, Net Profit Margin was -11.82 % — a change of 486.62% (lower).

Net Margin

-69.33 %

YoY

486.62%

Last updated:

Net Profit Margin of Vectorite Biomedical is 2026 -69.33 % . Net Profit Margin of Vectorite Biomedical was 2025 -11.82 % . It decreases by 486.62% lower compared to the previous year.

For Vectorite Biomedical, the net margin of -69.3% is up versus -277.8% a few years ago.

Access this data via the Eulerpool API

Vectorite Biomedical Stock analysis

What does Vectorite Biomedical do? Vectorite Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vectorite Biomedical stock

Net Profit Margin of Vectorite Biomedical is -69.33 % in 2026.

Access this data via the Eulerpool API

Margins — Vectorite Biomedical

All Key Metrics — Vectorite Biomedical